The FDA approval of RECELL GO was a critical milestone for the company which I think will prove to be worth billions to the company over time.
In the near term, due to the organisation expansions prior to approval (salesforce, manufacturing facility, complementary product(s), international partnerships, new accounts, etc) I can see an achievable pathway to the next major milestones:
- FY24 commercial revenue: $78.5M+
- Cash flow breakeven GAAP profitability no later than Q3'25 (without the need for additional funding)
Ill try to post my reasoning/workings later but until then, I think the worst is behind us and the following sums it up pretty well:
Ann: AVITA Medical Announces FDA Approval of RECELL GO, page-22
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.73 |
Change
0.045(2.68%) |
Mkt cap ! $122.9M | |||
| Open | High | Low | Value | Volume |
| $1.71 | $1.74 | $1.70 | $650.7K | 379.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | $1.71 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.73 | 1506 | 1 |
View Market Depth
| Last trade - 16.10pm 18/07/2025 (20 minute delay) ? |
| AVH (ASX) Chart |